BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2842263)

  • 21. A role of red cell pyrimidine 5'-nucleotidase in experimental lead poisoning.
    Fujii H
    Arch Toxicol; 1979 Oct; 43(1):59-64. PubMed ID: 231420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between lead concentration in blood and the activities of erythrocyte pyrimidine 5'-nucleotidase and delta-aminolevulinate dehydratase in the mice exposed to lead.
    Tomokuni K; Ogata M
    Arch Toxicol; 1981 Mar; 47(1):67-9. PubMed ID: 6269517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low level lead and inhibition of erythrocyte pyrimidine nucleotidase.
    Angle CR; McIntire MS
    Environ Res; 1978 Oct; 17(2):296-302. PubMed ID: 233817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythrocyte nucleotides in children--increased blood lead and cytidine triphosphate.
    Angle CR; McIntire MS; Swanson MS; Stohs SJ
    Pediatr Res; 1982 Apr; 16(4 Pt 1):331-4. PubMed ID: 7079004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythrocyte pyrimidine-5'-nucleotidase activity as a sensitive indicator of lead exposure.
    Torrance JD; Mills W; Kilroe-Smith TA; Smith AN
    S Afr Med J; 1985 May; 67(21):850-2. PubMed ID: 2986302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a short, heavy exposure to lead dust upon blood lead level, erythrocyte delta-aminolevulinic acid dehydratase activity and urinary excretion of lead delta-aminolevulinic acid coproporphyrin. Results of a 6-month follow-up of two male subjects.
    Schütz A; Skerfving S
    Scand J Work Environ Health; 1976 Sep; 2(3):176-84. PubMed ID: 788149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of lead intoxication: clinical and biochemical studies.
    Miwa S; Ishida Y; Takegawa S; Urata G; Toyoda T
    Am J Hematol; 1981; 11(1):99-105. PubMed ID: 6267939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of effects of lead on the activity of erythrocyte pyrimidine 5'-nucleotidase and delta-aminolevulinate dehydratase in vivo and in vitro.
    Tomokuni K; Ogata M
    Arch Toxicol; 1980 Sep; 45(3):197-201. PubMed ID: 6257208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromatographic analysis of human erythrocyte pyrimidine 5'-nucleotidase from five patients with pyrimidine 5'-nucleotidase deficiency.
    Hirono A; Fujii H; Natori H; Kurokawa I; Miwa S
    Br J Haematol; 1987 Jan; 65(1):35-41. PubMed ID: 3028466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyrimidine nucleoside monophosphate kinase hyperactivity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
    Lachant NA; Zerez CR; Tanaka KR
    Br J Haematol; 1987 May; 66(1):91-6. PubMed ID: 3036196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerance to lead-induced porphyrin metabolic disorders following lead pretreatment in mice.
    Tomokuni K; Ichiba M
    Toxicol Lett; 1990 Dec; 54(2-3):215-20. PubMed ID: 2260119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of initial results of treatment of lead poisoning with EDTA].
    Petkova V; Adjarov D; Pavlova S; Naydenova E; Kerimova M; Kuneva T
    Med Lav; 1994; 85(4):299-308. PubMed ID: 7808345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythrocyte pyrimidine 5'-nucleotidase and deoxynucleotidase isozymes: metallosensitivity and kinetics.
    Cook L; Kubitschek C; Stohs S; Angle C
    Drug Chem Toxicol; 1988 Jun; 11(2):195-213. PubMed ID: 2841083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The third case of Doss porphyria (delta-amino-levulinic acid dehydratase deficiency) in Germany.
    Doss MO; Stauch T; Gross U; Renz M; Akagi R; Doss-Frank M; Seelig HP; Sassa S
    J Inherit Metab Dis; 2004; 27(4):529-36. PubMed ID: 15303011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Usefulness of delta-aminolevulinic acid in blood as an indicator of lead exposure].
    Morita Y; Sakai T; Araki S; Araki T; Masuyama Y
    Sangyo Igaku; 1993 Mar; 35(2):112-8. PubMed ID: 8510341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between blood lead and indicators of effect in cows environmentally exposed to lead.
    Telisman S; Prpić-Majić D; Kersanc A
    Toxicol Lett; 1990 Aug; 52(3):347-56. PubMed ID: 2389263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. delta-Aminolevulinic acid dehydratase activity, urinary delta-aminolevulinic acid concentration and zinc protoporphyrin level among people with low level of lead exposure.
    Wang Q; Zhao HH; Chen JW; Hao QL; Gu KD; Zhu YX; Zhou YK; Ye LX
    Int J Hyg Environ Health; 2010 Jan; 213(1):52-8. PubMed ID: 19733117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of delta-aminolevulinic acid in plasma using high-performance liquid chromatography: a sensitive indicator of lead effects.
    Morita Y; Araki S; Sakai T; Araki T; Masuyama Y
    Ind Health; 1994; 32(2):85-96. PubMed ID: 7806449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of lead exposure on the activity of erythrocyte pyrimidine 5'-nucleotidase and delta-aminolevulinic acid dehydratase in mice.
    Tomokuni K
    Tohoku J Exp Med; 1983 Jan; 139(1):27-32. PubMed ID: 6301100
    [No Abstract]   [Full Text] [Related]  

  • 40. Relation between reticulocyte count and characteristics of erythrocyte 5'-nucleotidase in dogs, cats, cattle and humans.
    Hossain MA; Yamato O; Yamasaki M; Otsuka Y; Maede Y
    J Vet Med Sci; 2003 Feb; 65(2):193-7. PubMed ID: 12655113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.